Doctors test higher radiation doses for bladder cancer
NCT ID NCT01104350
Summary
This early-stage study tested whether higher doses of targeted radiation therapy could be safely given alongside chemotherapy to treat bladder cancer. Researchers worked with 19 patients who had bladder cancer that hadn't spread to other parts of the body. The main goal was to find the highest radiation dose that patients could tolerate without severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Suffolk
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Memorial Sloan Kettering at Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering at Mercy Medical Center
Rockville Centre, New York, United States
Conditions
Explore the condition pages connected to this study.